Hypomethylation of tumor suppressor genes in odontogenic myxoma

Brazilian Dental Journal

Volumn 22, Issue 5, 2011, Pages 422-427

  Moreira, Paula Rocha ^a   Cardoso, Fabiano Pereira ^a   Brito, João Artur Ricieri ^a   Batista, Aline Carvalho ^b   Gomes, Carolina Cavaliéri ^a   Gomez, Ricardo Santiago ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Dental pulp; Methylation; Odontogenic myxoma; Tumor suppressor genes

Indexed keywords

CDKN1A PROTEIN, HUMAN; CDKN1B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOSINE; MESSENGER RNA; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; METABOLISM; ODONTOGENIC TUMOR; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOOTH PULP; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOSINE; DENTAL PULP; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; ODONTOGENIC TUMORS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 80054718291     PISSN: 01036440     EISSN: 18064760     Source Type: Journal    
DOI: 10.1590/S0103-64402011000500013     Document Type: Article

References (25)

1. Buchner A, Odell EW. Odontogenic myxoma/myxofibroma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and genetics. Head and neck tumours. WHO Classification of tumours. Lyon: IARC Press; 2005; p. 316.
2. Simon EN, Merkx MA, Vuhahula E, Ngassapa D, Stoelinga PJ. Odontogenic myxoma: a clinicopathological study of 33 cases. Int J Oral Maxillofac Surg 2004;33:333-337.
3. Leiser Y, Abu-El-Naaj I, Peled M. Odontogenic myxoma: A case series and review of the surgical management. J Cranio-Maxillofac Surg 2009;37:206-209.
4. Perdigão PF, Stergiopoulos SG, De Marco L, Matyakhina L, Boikos SA, Gomez RS et al. Molecular and immunohistochemical investigation of protein kinase a regulatory subunit Type 1A (PRKAR1A) in odontogenic myxomas. Genes Chromosomes Cancer 2005;44:204-211.
5. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002;108:475-487.
6. Nakahara Y, Shintani S, Mihara M, Hino S, Hamakawa H. Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg 2006;35:362-365.
7. Kishi M, Kakamura M, Nishimine M, Ikuta M, Kirita T, Konishi N. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 2005;41:161-169.
8. Moreira PR, Guimarães MM, Guimarães A, Diniz M, Gomes C, Brito J et al. Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. J Oral Pathol Med 2009;38:99-103.
9. Moreira PR, Guimaraes MM, Gomes CC, Diniz M, Brito J, Castro W et al. Methylation frequencies of cell-cycle associated genes in epithelial odontogenic tumors. Arch Oral Biol 2009;54:893-897.
10. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:39-44.
11. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
12. Brakensiek K, Langer F, Kreipe H, Lehmann U. Absence of p21(CIP1), p27(KIP1) and p57(KIP2) methylation in MDS and AML. Leuk Res 2005;29:1357-1360.
13. Park H-J, Yu E, Shim Y-H. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Cancer Lett 2006;233:271-278.
14. Zhang C, Li K, Wei L, Li Z, Yu P, Teng L et al. p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma. J Clin Pathol 2007;60:1249-1253.
15. Livak KJ, Schimittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 2001;25:402-408.
16. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994;79:573-582.
17. Weber A, Wittekind C, Tannapfel A. Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of head and neck. Pathol Res Pract 2003;199:391-397.
18. Li J, El-Naggar A, Mao L. Promoter methylation of p16 INK4a, RASSF1A and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer 2005;104:771-776.
19. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 2009;1:239-259.
20. Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis 2000, 21:461-467.
21. Watanabe Y, Maekawa M. Methylation of DNA in cancer. Adv Clin Chem 2010;52:145-167.
22. Salhia B, Baker A, Ahmann G, Auclair D, Fonseca R, Carpten J. DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors. Cancer Res 2010;70:6934-6944.
23. Sato K, Terai K, Ozaki M, Ueda Y, Katsuda S. Odontogenic myxofibroma with HMGA2 overexpression and HMGA2 rearrangement. Pathol Int 2010;60:760-764.
24. Iezzi G, Piattelli A, Rubini C, Artese L, Fioroni M, Carinci F. MIB-1, Bcl-2 and p53 in odontogenic myxomas of the jaws. Acta Otorhinolaryngol Ital 2007;27:237-242.
25. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000, 2:E65-E67.